OMAHA, Neb. (July 15, 2020)—The third annual MidWest Drug Development Conference has been postponed due to circumstances related to the COVID-19 pandemic.
OMAHA, Neb. (February 11, 2020)—With eight months before the third MidWest Drug Development Conference opens its doors, 11 Universities are already lined up to participate in the two-day event.
So far, the impressive list of participating institutions are:
- Mayo Clinic
- Ohio State University
- Purdue University
- University of Colorado Anschutz Medical Campus
- University of Iowa
- University of Kansas
- University of Kentucky
- University of Missouri
- University of Nebraska Medical Center
- University of Oklahoma
- WARF (Wisconsin Alumni Research Foundation)
OMAHA, Nebraska (January 6, 2020)—Due the continued success and popularity of the MidWest Drug Development Conference, the event will return for a third year and registrations are now open, planners announced today.
The conference will again span two days, featuring Midwestern university technologies, beginning on Monday, Oct. 5, and concluding the following day, Tuesday, Oct. 6. The same venue—the Capital District Marriott in downtown Omaha—will house the event.
OMAHA, Nebraska (November 18, 2019)—The second MidWest Drug Development conference held last month was another resounding success.
The conference featured 42 technology presentations from 18 Midwestern universities, and 30 different companies and investor groups. An estimated 240 one-on-one partnering meetings were held during the two-day event, opening the door to additional opportunities for each participating university.
Due to an unexpected level of interest, only a handful of waivers remain for the 2019 MidWest Drug Development Conference.
The special, discounted room rate available for early registrants of the second MidWest Drug Development Conference expires this Friday, Aug. 30.
The second MidWest Drug Development Conference will feature around 16 institutions from 12 states, condensing an area of 780,000 square miles into one location.
OMAHA, Neb. (May, 15, 2019)—The MidWest Drug Development Conference will enter its second year, and registrations are now open.
The event will feature the top therapeutic technologies from more than a dozen Midwestern medical research universities and institutions, including Mayo Clinic, the University of Wisconsin’s WARF, Colorado, Missouri, Nebraska and Notre Dame, to name a few.
OMAHA, Nebraska (January 30, 2019)—Due to the overall success and popularity of the inaugural MidWest Drug Development Conference last year, the event will return for a second year and registrations are now open, planners announced today.
The conference will again span two days, featuring Midwestern university technologies, beginning on Monday, Sept. 31, and concluding the following day, Tuesday, Oct. 1. The same venue—the Capital District Marriott in downtown Omaha—will house the event.